Colorectal Carcinoma and Emerging Targeted Therapies
- PMID: 30766127
- PMCID: PMC6375427
Colorectal Carcinoma and Emerging Targeted Therapies
Abstract
Targeted therapies for specific mutations in colorectal cancer have led to an increase in patient overall survival.
Conflict of interest statement
Author disclosures Peter T. Silberstein, MD, reports receiving payment for lectures from Bristol Myers and Celgene in the past. Drs. Khanal and Upadhyay report no actual or potential conflicts of interest with regard to this article.
References
-
- Siegel R, DeSantis C, Jemal A. Colorectal cancer statistics, 2014. CA Cancer J Clin. 2014;64(2):104–117. - PubMed
-
- American Cancer Society. Cancer Facts & Figures 2015. Atlanta, GA: American Cancer Society; 2015.
-
- Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65(1):5–29. - PubMed
-
- Lichtenstein P, Holm NV, Verkasalo PK, et al. Environmental and heritable factors in the causation of cancer—analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med. 2000;343(2):78–85. - PubMed
-
- Bingham SA, Day NE, Luben R, et al. European Prospective Investigation into Cancer and Nutrition. Dietary fibre in food and protection against colorectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC): an observational study. Lancet. 2003;361(9368):1496–1501. - PubMed
LinkOut - more resources
Full Text Sources